SCHEMBL216663

SCHEMBL216663

Fc1ccc(N2CC[N]CC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
MAPT P10636 3/20 0.57
MAPK1 P28482 2/20 0.57
LMNA P02545 2/20 0.57
HTT P42858 1/20 0.57
GFER P55789 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
TP53 P04637 3/20 0.52
KDM4E B2RXH2 2/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
NPC1 O15118 4/20 0.48
RAB9A P51151 4/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
POLB P06746 1/20 0.48
CA12 O43570 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2098644 0.92 MAPT (0.51) ALDH1A1MAPTMAPK1LMNAHTT
SCHEMBL10373626 0.83 MAPT (0.77) ALDH1A1MAPTMAPK1LMNAHTT
SCHEMBL16404482 0.78 MAPT (0.64) ALDH1A1MAPTMAPK1LMNAHTT
SCHEMBL1821338 0.78 ALDH1A1 (0.70) ALDH1A1MAPTMAPK1LMNAHTT
SCHEMBL7513534 0.77 LTA4H (0.47) ALDH1A1MAPTMAPK1LMNAHTT
SCHEMBL220360 0.77 HTR3E (0.57) ALDH1A1MAPTLMNAHTTGFER
SCHEMBL662317 0.77 MAPT (0.52) ALDH1A1MAPTLMNAGFERTDP1
SCHEMBL3183333 0.77 AKR1C3 (0.44) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL240624 0.77 ADRB1 (0.57) ALDH1A1MAPTLMNAHTTTDP1
SCHEMBL1447167 0.77 MLYCD (0.43) ALDH1A1LMNAGFERMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 300 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118019736-A Molecular gel compound designed based on cereblon protein and application thereof 标新生物医药科技(上海)有限公司 2024-05-10 CN claimed
CN-117986271-A Cell cycle regulator, and pharmaceutical preparation and application thereof 贵州大学 2024-05-07 CN claimed
CN-117586233-A Preparation and application of N- [ (1H-indol-4-yl) alkyl ] benzamide compound 沈阳药科大学 2024-02-23 CN claimed
CN-111606883-B Sulfur-containing compound based on glutarimide skeleton and application thereof 上海科技大学 2023-05-09 CN claimed
CN-115611885-A N-substituted-5- ((4-substituted pyrimidin-2-yl) amino) -1H-indole-2-carboxamide derivatives 厦门大学 2023-01-17 CN claimed
US-20220143002-A1 SULFUR-CONTAINING COMPOUND BASED ON GLUTARIMIDE SKELETON AND APPLICATION THEREOF SHANGHAITECH UNIVERSITY (CN) 2022-05-12 US claimed
EP-3932922-A1 SULFUR-CONTAINING COMPOUND BASED ON GLUTARIMIDE SKELETON AND APPLICATION THEREOF ShanghaiTech University (CN) 2022-01-05 EP claimed
CN-111606883-A Sulfur-containing compound based on glutarimide framework and application thereof 上海科技大学 2020-09-01 CN claimed
CN-110337293-A Therapeutic compound 新泽西鲁特格斯州立大学 2019-10-15 CN claimed
US-9676789-B2 Aminated derivative of homoharringtonine, preparation method therefor, and application thereof HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) 2017-06-13 US claimed
EP-0266549-B1 CINNAMYL AMINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1991-06-19 EP claimed
US-4999355-A Antiserotonine agents RHONE-POULENC (FR) 1991-03-12 US claimed
EP-0169581-B1 ANTITUSSIVE AND MUCUS REGULATING 2-SUBSTITUTED THIAZOLIDINES BOEHRINGER BIOCHEMIA ROBIN S.p.A. (IT) 1989-12-06 EP claimed
US-4857643-A Antitussive and mucus regulating 2-substituted thiazolidines BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) 1989-08-15 US claimed
EP-0266549-A1 Cinnamyl amines, process for their preparation and pharmaceutical compositions containing them BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1988-05-11 EP claimed
EP-0110781-B1 SUBSTITUTED (AMINO-2-ETHYL)-6-BENZOXAZOLINONES, THEIR PREPARATION AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM RIOM LABORATOIRES- C.E.R.M. (Société Anonyme) (FR) 1987-04-01 EP claimed
EP-0169581-A2 Antitussive and mucus regulating 2-substituted thiazolidines BOEHRINGER BIOCHEMIA ROBIN S.p.A. (IT) 1986-01-29 EP claimed
US-4556656-A HYPOTENSIVE, ANTIPSYCHOTIC, DIABETIC, AND ANALGESIC AGENTS THE UPJOHN COMPANY (US) 1985-12-03 US claimed
US-4521534-A Imidazo[2,1-a]pyrrolo[2,1-c][1,4]benzodiazepine derivatives, methods of preparation and use AYERST, MCKENNA & HARRISON, LTD. (CA) 1985-06-04 US claimed
EP-0049203-A1 Benzoxazolinones substituted in the 6-position by an amino-alcohol or amino-ketone chain, their preparation and their therapeutic use RIOM LABORATOIRES- C.E.R.M. (Société Anonyme) (FR) 1982-04-07 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220143002-A1 SULFUR-CONTAINING COMPOUND BASED ON GLUTARIMIDE SKELETON AND APPLICATION THEREOF GLS, SQOR, GCDH ALDH1A1 958/4885MAPT 54/4885MAPK1 2489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.